Details:
As part of the agreement, ASOFARMA will collaborate with Moderna in the management of supply contracts already in force, as well as in vaccine registration processes, support for pharmacovigilance activities, and generation of new agreements for the availability of SPIKEVAX.
Lead Product(s): Elasomeran
Therapeutic Area: Infections and Infectious Diseases Product Name: Spikevax
Highest Development Status: Approved Product Type: Vaccine
Partner/Sponsor/Collaborator: Moderna Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration February 23, 2022